100

Past ClinicalTrials.gov quality signals, not current performance

This is a retrospective look at registry quality signals in ClinicalTrials.gov, not a report of current performance.

[1][2]

The registry-record analysis examined 79,413 ClinicalTrials.gov records.

[3]

In the planned-analysis sample, 61% of first primary outcome entries were too vague to identify a measurement or domain.

[4][5]

The posted-results review analyzed 2,178 publicly posted results records.

[6]

Among posted results records, 20% reported more than two primary outcomes, and sponsors or investigators self-reported the data without an independent verification source.

[7][8]